Evidence map›Paper›PMID 37770671›Full record

ArticleBiological trace element research2024

Anti-Inflammatory Effects of Boric Acid in Treating Knee Osteoarthritis: Biochemical and Histopathological Evaluation in Rat Model.

Koksal Gundogdu, Gulsah Gundogdu, Fatma Demirkaya Miloglu, Tuba Demirci, Seymanur Yılmaz Tascı, A M Abd El-Aty

Abstract read
PubMed Publisher
In one paragraph

Article in Biological trace element research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Koksal GundogduDepartment of Orthopedics and Traumatology, Denizli State Hospital, Denizli, Turkey.
Gulsah GundogduDepartment of Physiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey. gdemirkaya81@gmail.com.ORCID http://orcid.org/0000-0002-9924-5176
Fatma Demirkaya MilogluDepartment of Analytical Chemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey.
Tuba DemirciDepartment of Histology and Embryology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Seymanur Yılmaz TascıDepartment of Physiology, Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey.
A M Abd El-AtyDepartment of Medical Pharmacology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to examine the anti-inflammatory properties of boric acid (BA) in treating knee osteoarthritis (KOA) in rats, evaluating its biochemical and histopathological therapeutic effects. A KOA rat model was induced by injecting monosodium iodoacetate into the knee joint. Random assignment was performed for the experimental groups as follows: group-1(control), group-2(KOA control), group-3 (BA:4 mg/kg, orally), group-4(BA:10 mg/kg, orally), group-5(BA:4 mg/kg, intra-articularly), and group-6(BA:10 mg/kg, intra-articularly). The rats received 100 µL of BA intra-articularly on days 1, 7, 14, and 21 or 1 mL orally once a day (5 days/week) for 4 weeks. Serum levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and activity of matrix metalloproteinase-13 (MMP-13) were measured. Histopathological and immunohistochemical analyses were performed on knee joint samples using specific antibodies for IL-1β, TNF-α, MMP-13, and nitric oxide synthase-2 (NOS-2). Group-2 exhibited higher serum IL-1β and TNF-α levels and MMP-13 activity than group-1 (P < 0.05). However, IL-1β and TNF-α levels and MMP-13 activity were lower in all treatment groups than in group-2, with statistically significant reductions observed in groups-4, 5, and 6. Histopathologically, group-2 displayed joint space narrowing, cartilage degeneration, and deep fissures. Groups-5 and 6 demonstrated significant joint space enlargement, articular cartilage tissue regeneration, and immunostaining patterns similar to those in group-1. Immunohistochemically, group-2 showed significant increases in IL-1β, TNF-α, MMP-13, and NOS-2 expression. However, all treatment groups exhibited reductions in these expression levels compared to group-2, with statistically significant decreases observed in groups-5 and 6 (P < 0.01). BA shows potential efficacy in reducing inflammation in experimental KOA model in rats. It may be a promising therapeutic agent for KOA, warranting further clinical studies for validation.

Indexed as

Anti-Inflammatory AgentsBoric AcidsDisease Models, AnimalOsteoarthritis, KneeAnimalsInterleukin-1betaMaleMatrix Metalloproteinase 13RatsRats, Sprague-DawleyRats, WistarTumor Necrosis Factor-alphaAnti-Inflammatory Agentsboric acidBoric AcidsInterleukin-1betaMatrix Metalloproteinase 13Tumor Necrosis Factor-alphaAnti-inflammatory effectBiochemical evaluationBoric acidHistopathological analysisKnee osteoarthritisRat model

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.